U.S. government debt prices were slightly higher Thursday morning as concerns over rising coronavirus cases stateside and U.S.-China tensions tempered optimism arising from progress toward a vaccine.
said its potential Covid-19 vaccine had produced a strong immune response in early-stage human trials.
However, cases of the coronavirus continue to surge in the U.S., with Texas reporting a record daily rise in new cases on Wednesday as nationwide infections reach 3.5 million. Meanwhile, relations between Washington and Beijing continue to sour, as U.S. Secretary of State Mike Pompeo on Wednesday saying that the U.S. will impose visa restrictions on Chinese companies such as tech giant Huawei, which he accused of facilitating human rights violations.
The White House also said that President Donald Trump has not ruled out imposing sanctions on Chinese officials as part of the Hong Kong Autonomy Act, the punitive measures signed Tuesday against China for its handling of Hong Kong. Key economic data will be on investors' radar on Thursday, with June's U.S. retail sales figures due at 8:30 a.m. ET, an indicator of the extent to which activity continued to recover as lockdown measures were lifted. Last week's jobless claims figures are also due at 8:30 a.m. ET, with analysts expecting 1.29 million new claims after the
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Treasury yields retreat as coronavirus surge tempers vaccine optimismU.S. government debt prices were higher Tuesday morning as a continued surge of coronavirus cases stateside tempered hopes of recovery on the back of Monday's promising vaccine news.
Read more »
Treasury yields climb, following stock-market’s cue on vaccine optimismU.S. Treasury yields rose Wednesday as equities markets rallied on reports of progress on a coronvirus vaccine from two pharmaceutical companies that raise the chances of an economic recovery from the pandemic.
Read more »
Promising results from Moderna's first trial as they aim to start final phaseThe phase 3 trial aims to answer the big question: Does the coronavirus vaccine work?
Read more »
European stocks head for higher open on vaccine hopesEuropean stocks are expected to open higher Wednesday as investor hopes for a coronavirus vaccine rise.
Read more »
Volunteers sought for next phase of COVID-19 vaccine trial in U.S., starting at end of JulyThe phase 3 trial aims to answer the big question: Does the coronavirus vaccine work?
Read more »
Moderna stock surges after releasing promising coronavirus vaccine trial dataModerna's stock surged early Wednesday after the biotech company said its potential coronavirus vaccine generated a promising immune response in an early-stage human trial.
Read more »